Literature DB >> 6300424

Recombinational junctions of variants of Moloney murine sarcoma virus: generation and divergence of a mammalian transforming gene.

D J Donoghue, T Hunter.   

Abstract

Different variants of Moloney murine sarcoma virus (MSV) were examined by nucleotide sequencing to compare the junctions between the acquired cellular sequence, v-mos, and the adjacent virus-derived sequences. These variants included 124-MSV, m1-MSV, and HT1-MSV and also the purportedly independent isolate Gazdar MSV. These four strains have an identical 5' junction between the murine leukemia virus env gene and the v-mos gene. This junction lies within the sixth codon of the chimeric env-mos coding region that encodes the transforming gene product. In contrast, at the 3' junction between the v-mos gene and the murine leukemia virus env gene, the three variants examined here were all different. A small deletion was found in the COOH-terminal portion of the m1-MSV env-mos coding region, indicating that the COOH terminus of this transforming gene product must be different from that of 124-MSV or HT1-MSV. The data presented here are consistent with the thesis that a virus closely related to HT1-MSV was the primordial Moloney MSV, and that all other related strains evolved from it by deletion or rearrangement. The variability observed in the Moloney MSV family is discussed in terms of possible mechanisms for the initial capture of mos sequences by the parental retrovirus and also in comparison with other transforming retrovirus families, such as Abelson murine leukemia virus and Rous sarcoma virus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300424      PMCID: PMC256455     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Evidence for helper independent murine sarcoma virus. I. Segregation of replication-defective and transformation-defective viruses.

Authors:  J Ball; J A McCarter; S M Sunderland
Journal:  Virology       Date:  1973-11       Impact factor: 3.616

2.  Evidence for naturally occurring murine sarcoma virus.

Authors:  J K Ball; D Harvey; J A McCarter
Journal:  Nature       Date:  1973-01-26       Impact factor: 49.962

3.  Properties of clonal lines of murine sarcoma virus transformed Balb-3T3 cells.

Authors:  G J Todaro; S A Aaronson
Journal:  Virology       Date:  1969-05       Impact factor: 3.616

4.  A virus-induced rhabdomyosarcoma of mice.

Authors:  J B Moloney
Journal:  Natl Cancer Inst Monogr       Date:  1966-09

5.  Biological, pathological and physical characterization of a possible variant of a murine sarcoma virus (Moloney).

Authors:  M A Chirigos; D Scott; W Turner; K Perk
Journal:  Int J Cancer       Date:  1968-03-15       Impact factor: 7.396

6.  Rescue of the defective genome of Moloney sarcoma virus from a noninfectious hamster tumor and the production of pseudotype sarcoma viruses with various murine leukemia viruses.

Authors:  R J Huebner; J W Hartley; W P Rowe; W T Lane; W I Capps
Journal:  Proc Natl Acad Sci U S A       Date:  1966-10       Impact factor: 11.205

7.  Transformation of mouse 3T3 cells by murine sarcoma virus: release of virus-like particles in the absence of replicating murine leukemia helper virus.

Authors:  R H Bassin; L A Phillips; M J Kramer; D K Haapala; P T Peebles; S Nomura; P J Fischinger
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

8.  Comparison of murine sarcoma viruses in nonproducer and S + L - -transformed cells.

Authors:  S A Aaronson; R H Bassin; C Weaver
Journal:  J Virol       Date:  1972-04       Impact factor: 5.103

9.  Properties of a murine sarcoma virus isolated from a tumor arising in an NZW-NZB F 1 hybrid mouse. I. Isolation and pathology of tumors induced in rodents.

Authors:  A F Gazdar; H C Chopra; P S Sarma
Journal:  Int J Cancer       Date:  1972-01-15       Impact factor: 7.396

10.  Reversion of murine sarcoma virus transformed mouse cells: variants without a rescuable sarcoma virus.

Authors:  P J Fischinger; S Nomura; P T Peebles; D K Haapala; R H Bassin
Journal:  Science       Date:  1972-06-02       Impact factor: 47.728

View more
  11 in total

Review 1.  3' junctions of oncogene-virus sequences and the mechanisms for formation of highly oncogenic retroviruses.

Authors:  J Zhang; H M Temin
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

2.  Nucleotide sequence of the transforming gene of m1 murine sarcoma virus.

Authors:  M A Brow; A Sen; J G Sutcliffe
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

3.  Biologically active mutants with deletions in the v-mos oncogene assayed with retroviral vectors.

Authors:  R J Bold; D J Donoghue
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

4.  Studies on the pathology, especially brain lesions, induced by R7, a spontaneous mutant of Moloney murine sarcoma virus 124.

Authors:  P H Yuen; Y T Kwak
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

5.  Comparison of myeloproliferative sarcoma virus with Moloney murine sarcoma virus variants by nucleotide sequencing and heteroduplex analysis.

Authors:  A Stacey; C Arbuthnott; R Kollek; L Coggins; W Ostertag
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

6.  Molecular cloning and characterization of a leukemia-inducing myeloproliferative sarcoma virus and two of its temperature-sensitive mutants.

Authors:  R Kollek; C Stocking; F Smadja-Joffe; W Ostertag
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

7.  Mouse c-mos oncogene activation is prevented by upstream sequences.

Authors:  T G Wood; M L McGeady; B M Baroudy; D G Blair; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  Genesis of Kirsten murine sarcoma virus: sequence analysis reveals recombination points and potential leukaemogenic determinant on parental leukaemia virus genome.

Authors:  J D Norton; J Connor; R J Avery
Journal:  Nucleic Acids Res       Date:  1984-09-11       Impact factor: 16.971

9.  Nucleotide sequence and biochemical activities of the Moloney murine sarcoma virus strain HT-1 mos gene.

Authors:  A Seth; G F Vande Woude
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

10.  Lysine residue 121 in the proposed ATP-binding site of the v-mos protein is required for transformation.

Authors:  M Hannink; D J Donoghue
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.